Floatz logo

14 assets in Primary Myelofibrosis

Therapeutic assets addressing Primary Myelofibrosis, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Ruxolitinib
Primary Myelofibrosis
OHSU Knight Cancer InstituteP4BBB (73)
Tacrolimus
Primary Myelofibrosis
City of Hope Medical CenterP2BB (68)
Panobinostat
Primary Myelofibrosis
OHSU Knight Cancer InstituteP4BB (65)
Cyclophosphamide
Primary Myelofibrosis
City of Hope Medical CenterP2B (63)
Decitabine
Primary Myelofibrosis
University of WashingtonP2B (60)
Azacitidine
Primary Myelofibrosis
M.D. Anderson Cancer CenterP1/2B (59)
Venetoclax
Primary Myelofibrosis
OHSU Knight Cancer InstituteP1/2CCC (54)
Fedratinib
Primary Myelofibrosis
University of WashingtonP2CCC (53)
Pevonedistat
Primary Myelofibrosis
M.D. Anderson Cancer CenterP1/2CCC (48)
Itacitinib
Primary Myelofibrosis
City of Hope Medical CenterP2CC (47)
Pacritinib
Primary Myelofibrosis
University of WashingtonP2CC (46)